In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...